Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

• Main Authors: Ngoc Huu Tran (Author), Danaya Chansinghakul (Author), Chia Yin Chong (Author), Chian Yong Low (Author), Lynette P. Shek (Author), Chan Quang Luong (Author), Carina Frago (Author), T. Anh Wartel (Author), Sunny Sun (Author), Anna Skipetrova (Author), Alain Bouckenooghe (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...